News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,688 Results
Type
Article (85282)
Company Profile (623)
Press Release (738783)
Section
Business (231883)
Career Advice (4091)
Deals (39623)
Drug Delivery (106)
Drug Development (90443)
Employer Resources (192)
FDA (17892)
Job Trends (17246)
News (394675)
Policy (39586)
Tag
Academia (2973)
Africa (1263)
Alliances (56346)
Alzheimer's disease (1250)
Approvals (17802)
Arizona (210)
Artificial intelligence (86)
Asia (49011)
Australia (8618)
Bankruptcy (392)
Best Places to Work (12266)
Biotechnology (438)
C2C Services and Suppliers (95111)
California (2062)
Canada (959)
Cancer (555)
Career advice (3498)
Cell therapy (145)
China (159)
Clinical research (70476)
Collaboration (160)
Colorado (88)
Compensation (85)
Connecticut (86)
COVID-19 (2756)
Cystic fibrosis (78)
Data (326)
Diabetes (92)
Diagnostics (6504)
Drug pricing (86)
Earnings (93535)
Employer resources (162)
Europe (112061)
Events (125043)
Executive appointments (167)
FDA (18132)
Florida (278)
Funding (158)
Gene therapy (110)
GLP-1 (623)
Government (5011)
Healthcare (20656)
Hotbed/Location (534575)
Illinois (324)
Indiana (163)
Infectious disease (2790)
Inflammatory bowel disease (103)
Interviews (804)
IPO (17499)
Job creations (5172)
Job search strategy (2850)
Kansas (100)
Layoffs (468)
Legal (10014)
Lung cancer (127)
Manufacturing (105)
Maryland (439)
Massachusetts (1743)
Medical device (14271)
Medtech (14276)
Mergers & acquisitions (21969)
Metabolic disorders (304)
Michigan (138)
Minnesota (236)
Neuroscience (1421)
New Jersey (625)
New York (631)
NextGen Class of 2024 (7622)
Non-profit (5054)
North Carolina (706)
Northern California (853)
Obesity (181)
Ohio (111)
Opinion (234)
Patents (83)
Pennsylvania (603)
People (63738)
Pharmaceutical (119)
Phase I (21639)
Phase II (30597)
Phase III (23118)
Pipeline (116)
Podcasts (76)
Postmarket research (3532)
Preclinical (9774)
Press Release (72)
Rare diseases (143)
Real estate (7363)
Recruiting (72)
Regulatory (25613)
Research institute (2633)
Resumes & cover letters (645)
South America (1641)
Southern California (795)
Startups (4273)
Texas (272)
United States (9511)
Vaccines (570)
Washington State (284)
Weight loss (173)
Date
Today (87)
Last 7 days (663)
Last 30 days (2587)
Last 365 days (39868)
2024 (28351)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 824,688 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight Loss
Novo’s Next-Gen CB1 Drug Leads to Weight Loss in Phase II, but Neuropsychiatric Events Reported
Novo Nodrisk’s cannabinoid receptor–targeting obesity pill was picked up in the $1.1 billion acquisition of Inversago Pharmaceuticals last year.
September 20, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Stryker completes acquisition of NICO Corporation, expanding minimally invasive solutions for brain tumor removal and stroke care
September 20, 2024
·
2 min read
Press Releases
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
September 20, 2024
·
4 min read
Press Releases
Ipsen’s Iqirvo® (elafibranor) approved in the European Union as first new treatment for primary biliary cholangitis in nearly a decade
September 20, 2024
·
11 min read
Press Releases
Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed
September 20, 2024
·
3 min read
Press Releases
Laurel K. Leslie, MD, MPH, Named Director of the Mental and Behavioral Health Institute at Cincinnati Children’s
September 20, 2024
·
5 min read
Press Releases
Koelis Announces Partnership and Initial Experience with DeepHealth for AI-powered Prostate MRI Interpretation and Guidance in Fusion Biopsy
September 20, 2024
·
3 min read
Press Releases
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
September 20, 2024
·
7 min read
Press Releases
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum
September 20, 2024
·
3 min read
Press Releases
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
September 20, 2024
·
6 min read
1 of 82,469
Next
